Lotus Health Group to unlock shares, changes auditor

Lotus Health Group Company will lift restrictions on 1,807,500 shares from its 2023 stock option and restricted share incentive plan on November 26, 2025. This follows the fulfillment of performance conditions, with the company’s 2024 operating revenue growing by 56.73% to 2,646,440,493.77 yuan compared to 2022. The 61 eligible incentive recipients, including management and core staff, will see their shares and options become unrestricted.

Concurrently, Lotus Health Group announced a change in its auditing firm for the 2025 fiscal year, appointing Tianjian Certified Public Accountants to replace Zhongxingcai Guanghua Certified Public Accountants. Zhongxingcai Guanghua had served as the company’s auditor for nine consecutive years. The decision to switch auditors was made to ensure independence, objectivity, and fairness, in line with regulatory requirements.

The total audit fee for 2025 with Tianjian is provisionally set at 1,350,000 yuan, comprising 950,000 yuan for financial report audits and 400,000 yuan for internal control audits. Both the share restriction lift and the auditor change were approved by the board of directors and its committees, with the latter still subject to shareholder approval.